Exagen (XGN) Enterprise Value (2018 - 2026)

Exagen (XGN) has reported Enterprise Value for 9 consecutive years, with -$21.5 million the latest figure, recorded in Q1 2026.

• Enterprise Value for Q1 2026 came in at -$21.5 million, down 92.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$21.5 million (down 92.18% YoY), and the FY2025 annual result was -$32.2 million, down 46.22% from the prior year.
• Enterprise Value was -$21.5 million for Q1 2026 at Exagen, up from -$32.2 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$11.2 million in Q1 2025 and troughed at -$89.8 million in Q1 2022.
• Average Enterprise Value over 5 years is -$39.5 million, with a median of -$31.5 million recorded in 2023.
• Year-over-year, Enterprise Value soared 59.0% in 2025 and tumbled 92.18% in 2026.
• Over 5 years, Enterprise Value stood at -$62.4 million in 2022, then soared by 41.51% to -$36.5 million in 2023, then soared by 39.62% to -$22.0 million in 2024, then tumbled by 46.22% to -$32.2 million in 2025, then jumped by 33.23% to -$21.5 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$21.5 million in Q1 2026, -$32.2 million in Q4 2025, and -$35.7 million in Q3 2025.